Loading

JSM Burns and Trauma

Burns Fluid Resuscitation with Considerations for Changing Target Goals

Editorial | Open Access | Volume 3 | Issue 1

  • 1. Consultant Plastic Surgeon, King Fahad Central Hospital, Saudi Arabia
+ Show More - Show Less
Corresponding Authors
Pramod Kumar, Consultant Plastic Surgeon, King Fahad Central Hospital, Jizan, Saudi Arabia, Tel: 91-9986230334;
Citation

Kumar P (2018) Burns Fluid Resuscitation with Considerations for Changing Target Goals. JSM Burns Trauma 3(1): 1038

EDITORIAL

The ideal resuscitation fluid is one that produces a sustained increase in intra vascular volume without any change in chemical composition of body fluid or any adverse metabolic effect [1]. For effective resuscitation by crystalloids, usually rapid transfusion of large volume of Ringer’s lactate is required which often results in extreme elevation of total body sodium and water content (interstitial edema especially if associated with hypoproteinemia/ albuminemia). Due to edema, if there is compression of venous drainage at thoracic inlet it may exaggerate edema over head and neck area [2].

Resuscitation end point (target goal)

Though best clinical guideline for adequate resuscitation is urine output 1-2ml /Kg/ hour. Also, commonly in practice systolic arterial pressure (SAP) ‘≥ 100 mmHg OR ≥ 80% baseline value’ is taken as resuscitation end point [3]. The mean arterial pressure (MAP) is a better determinant of organ perfusion than SAP. Hence, it is important to take MAP ≥ 60 mmHg as end point in case of hypovolemia without significant increase in capillary permeability, but in SIRS or sepsis it is better to take all of following as end point guidelines: CVP 8-12 mm Hg (if available/ not contraindicated in burn patients), MAP ≥ 65 mm Hg, Urine output ≥ 0.5 mL/kg/hr, and Central venous oxygen pressure (Scvo2) ≥ 70% (The 2016 Surviving Sepsis Guidelines) [4,5].

Though there is low quality of available evidence, it is better to normalize lactate (Lactate ≥ 4 mmol/L) in patients with elevated lactate levels as a marker of tissue hypo perfusion [4]. For the purpose of convenience of description the subject will be discussed in three heads

Fluid volume

Parkland and Brooke formula are commonly used as guide to initial fluid resuscitation. For more than 25 years in my practice, use of modified Brooke formula (2ml/Kg/% body surface area burn crystalloid + daily requirement during first 24 hour (first half in first 8hours and next half in next 16 hours); 1ml/Kg/% body surface area burn crystalloid + daily requirement during next 24 hour) as initial guide to fluid resuscitation has given quite satisfactory result. Albumin transfusion is avoided in first 24 hours. This volume may be changed in major amputee cases according to the corrected total surface area burn (CTBSA=TBSA x (100/100-surface area of amputated part) [6]. Response to same resuscitation fluid volume may vary from patient to patient due to several reasons. Even if other variables are kept constant, only burn depth index in same size of burn in two different but comparable patients may considerably influence the response to fluid resuscitation [7]. First degree burn is subtracted from TBSA burn for the purpose of fluid calculation. It is better to limit TBSA burn to 50% for the purpose of fluid calculation in very extensive burn (>50% TBSA burn) and later modify fluid volume as per response in next 3 hours.

In absence of any complication of excess fluid transfusion, if target end point is not reached with modified Brooke formula, relatively larger volume (up to 30%) with or without inotrops/ vasopressors may be considered. In case of resuscitation end point not reached within 48 hours or in cases of SIRS/sepsis 30ml/kg crystalloid is transfused for 6 hours and reassessed for re-fixation of new target end point and rate of transfusion. Hypovolemic shock due to delayed resuscitation may require increased fluid volume by 30% for adequate resuscitation; but if stage of irreversible shock is attained, patient may not respond to fluid resuscitation. To avoid mechanical blockade of renal tubules due to myoglobinuria and hemoglobinuria in extensive 3rd degree burn and electric burn, urine output is maintained at 100-150ml/hour by transfusing more fluid and if required by use of diuretics (osmotic). To avoid precipitation of myoglobin and hemoglobin, urine is made alkaline by intravenous soda bicarbonate at frequent intervals. In response to burn trauma, excess circulating catecholamine may cause renal vessel spasm with reduced urine output in spite of adequate fluid transfusion. In these cases low dose dopamine (3-5 microgram/kg/minute) can produce desirable effect by increasing renal perfusion.

Leak of transfused fluid due to increased capillary permeability may lead to subcutaneous compartment syndrome [8,9] with tissue ischemia and conversion of superficial burn to deep burn [10]. To reduce resuscitation fluid volume albumin transfusion or bolus resuscitation may be considered. The bolus resuscitation with albumin or saline (FEAST- Fluid expansion as supportive therapy) in pediatric population has shown to increase death rate significantly [11,12]. Large volume fluid transfusion in extensive burn patients, semi-recumbent position and elective mechanical ventilation with increased airway pressure and higher PEEP within permissible limits may be helpful in protecting from pulmonary edema. Incisions/eschorotomy/punctured wounds over burnt area and intermittent negative pressure dressings (e.g. Limited access dressing) [13], may protect from problems of excessive subcutaneous fluid collection. In burn patients abdominal compartment syndrome (intra-abdominal pressure > 30 cm H2 O) associated with large volume resuscitation may increase mortality by 70-100% [14]. Eschorotomy (H shape) over abdomen with two vertical limbs of H on either side of abdomen helps to relieve the intra-abdominal pressure. Fluid overload may increase interstitial edema of kidney and compress capillaries with increased intra tubule pressure leading to reduced filtration gradient with consequent acute kidney injury (AKI). Hence, use of diuretics at the point of onset of oliguria after desired volume transfusion may be beneficial in reducing kidney interstitial edema and possible excretion of proinflammatory chemicals in urine with obvious advantages. In cases of inhalation injury and renal inefficiency, it is better to do arterial blood gas analysis (ABG) at repeated intervals to diagnose and treat acid base balance abnormalities.

If MAP target is not achieved by initial fluid as per standard fluid formula, CVP measurement is indicated and established resuscitation protocols are used to change the course of the treatment. Use of vasopressor (noradrenaline) in hypovolemia along with altered capillary permeability may produce tissue ischemia due to vasoconstriction; and consequent oxidative stress may lead to exaggerated inflammatory cascade leading to poor prognosis. Hence, once CVP target is achieved by crystalloid or colloid and MAP target is not achieved, and cardiac cause/ other causes of hypotension is excluded; serum albumin/albumin + globulin level correction should be considered. Vasopressor and inotrops may be required as adjunct therapy (noradrenaline 0.4 mg/hour to 0.8 mg/hour noradrenaline base (0.8 mg/hour to 1.6 mg/hour noradrenaline tartrate); i.e 40 mg/litre noradrenaline base (80 mg/litre noradrenaline tartrate) at the rate of 0.16 to 0.33 ml/min; addition of vasopressin 0.03units/minute has been recommended to reduce nor-adrenaline dose. If MAP target is not achieved phenylephrine 200-300microgram/minute may be added [15]. Once MAP target is achieved, Scvo2 level should be checked to determine end of resuscitation. If Scvo2 target is not achieved, packed red blood cells should be transfused to raise hematocrit by 30%. Once target end point of resuscitation is achieved further step down therapy is started. If alteration of course fails, transition to comfort care is planned.

The resuscitation failure is considered to exist when at least one major complication of fluid overload (pulmonary edema, abdominal compartment syndrome, subcutaneous compartment syndrome, multi-organ dysfunction and failure) appears during resuscitation [15]. Failure to resuscitate by standard protocol fluid volume are usually due to delayed resuscitation, cardiac dysfunction because of carbon monoxide poisoning, coronary artery disease, and old age; occurrence of sepsis, MODS and MOF

Use of stroke volume optimization is a better guide to fluid therapy than central venous pressure (CVP) and urine output measurement. Clinically low stroke volume may not be precisely indicated clinically by tachycardia, reduced cardiac output urine output, reduced SpO2, and hypotension. Development of newer technologies for estimation of instant blood volume in critical patients may be a better idea in stroke volume stabilization [16,17]. Also, instant blood volume measurement along with CVP may prove to be a better guide to remove accumulated excess transfused volume by continuous renal replacement therapy (CRRT)/use of diuretics (in case of normal kidney function) in cases of subcutaneous and abdominal compartment syndrome, pulmonary edema and AKI.

ROLE OF COLLOID TRANSFUSION

Large amount of albumin (4%) transfusion or saline as resuscitation fluid has been shown to be associated with significant increase in rate of death/ organ failure [18,19]. Albumin transfusion as early resuscitation fluid in children at 2 year age with brain injury has been shown to significantly increase in death as compared to saline as resuscitation fluid [20]. Serial serum protein study [21] to calibrate/grade the capillary pore size, may be a better guide for albumin transfusion to reduce the chances of albumin leak. Albumin transfusion should be avoided in first 24 hours. It is better to consider albumin transfusion if serum albumin level is less than 20gram/L. It is safer to transfuse 5% albumin 0.5–1 g/kg/% burn per day till serum albumin reaches at the level of 30gram/L [21]. It will be better to transfuse larger protein molecule (e.g. globulin) if capillary pore size is larger than albumin size [22]

MANIPULATION OF CAPILLARY PERMEABILITY AS A PRIMARY GOAL OF RESUSCITATION

Following burns and trauma platelet degranulation, and local complement activation (in response to oxidative damage following ischemia and reperfusion to endothelial cell membrane, neutrophil adhesion to endothelium and by apoptotic endothelium) leads to inflammatory response causing local vasodilatation, increased capillary permeability, and further recruitment and activation of neutrophils leading to reperfusion injury. This response is further amplified by release of TNF-alpha and interleukins from activated neutrophils [1,2]. In addition to oxidative stress, supra-physiological loads of glucocorticoids (exogenous/ endogenous), subsequent infection (bacterial degradation/toxins) and other similar insults e.g. shock, surgical trauma (multi hit theory) leads to an inflammatory cascade (acute phase protein synthesis, up regulation of inflammatory adhesion molecules and pro-inflammatory cytokine) [3-5]. When these molecules and cytokines are absorbed in systemic circulation, it produces systematic inflammatory response syndrome/ sepsis (in presence of infection) that ultimately may lead to MODS/ MOF with poor prognosis. Hence, Oxidative damage, ischemia, reperfusion, change in capillary permeability (with loss of fluid, electrolyte and serum protein leading to shock), are main factors that serve as guide to fluid therapy. Apart from this any preexisting disease (kidney, lungs, heart) or trauma to other organs also regulate fluid resuscitation.

Also, as the changed capillary permeability persists for an unspecified period, the controversy in resuscitation may reduce if we study it and target capillary pore normalization [22] as primary therapeutic goal and use current resuscitation goal as supportive therapy goal. Also, the accumulated excess Also, as the changed capillary permeability persists for an unspecified period, the controversy in resuscitation may reduce if we study it and target capillary pore normalization [22] as primary therapeutic goal and use current resuscitation goal as supportive therapy goal. Also, the accumulated excess

REFERENCES

1. Myburgh JA, Mythen MG. Resuscitation fluids. N Engl J Med. 2013; 369: 1243-1251.

2. Kumar P, Furtado S. Atypical post burn oedema presenting with obstruction of veins at the thoracic inlet. Burns. 1997; 23: 631-633.

3. Klohr S, Roth R, Hofmann T, Rossaint R, Heesen M. Definitions of hypotension after spinal anaesthesia for caesarean section: literature search and application to parturients. Acta Anaesthesiol Scand. 2010; 54: 909-921.

4. Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving Sepsis Campaign: International Guidelines for the Management of Sepsis and Septic Shock: 2016. Crit Care Med. 2017; 43: 304-377.

5. Dellinger RP, Schorr CA, Levy MM. A Users’ Guide to the 2016 Surviving Sepsis Guidelines. Crit Care Med. 2017; 45: 381-385.

6. Tiwari VK, Kumar P. Modified fluid regimen for an extensively burned patient with a previous major amputation. Burns. 1989; 15: 412.

7. Kumar P, Kumar P. Burns depth index and classification of burns casualties. Burns. 1993; 19:252.

8. Kumar P. Subcutaneous compartment syndrome. Burns. 2007; 33: 125-1266. 9. Kumar P. Subcutaneous compartment syndrome in burns. JSM Burns Trauma. 2017; 2: 1026.

10. Kumar P. Fluid resuscitation for burns: a double edge weapon. Burns. 2002; 28: 613-614.

11. Maitland K, Kiguli S, Opoka RO, Engoru C, Olupot-Olupot P, Akech SO, et al. Mortality after fluid bolus in African children with severe infection. N Engl J Med. 2011; 364: 2483-2495.

12. Maitland K, George E, Evans J, Kiguli S, Olupot-Olupot P, Akech SO, et al. Exploring mechanisms of excess mortality with early fluid resuscitation: insights from the FEAST trial. BMC Med. 2013; 11: 68.

13. Kumar P. Exploiting potency of negative pressure in wound dressing using limited access dressing and suction-assisted dressing. Indian J Plast Surg. 2012; 45: 302-315.

14. Alvarado R, Chung KK, Cancio LC, Wolf SE. Burn resuscitation. Burns. 2009; 35: 4-14.

15. Brownson EG, Pham TN, Chung KK. How to Recognize a Failed Burn Resuscitation. Crit Care Clin. 2016; 32: 567-575.

16. Kumar P, Kumar R, Pandit N. Estimation of blood volume in burns patients using radioisotope chromium-51: A pilot study. Burns. 2008; 33: 1072-1073.

17. Baby PM, Kumar P, Kumar R, Jacob SS, Rawat D, Binu VS, et al. A novel method for blood volume estimation using trivalent chromium in rabbit models. Indian J Plast Surg. 2014; 47: 242-248.

18. Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ. 1998; 317: 235-240.

19. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R. SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004; 350: 2247- 2256.

20. Idem. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med. 2007; 357: 874-884.

21. Haberal M, Sakallioglu Abali AE, Karakayali H. Fluid management in major burn injuries. Indian J Plast Surg. 2010; 43: 29-36.

22. Kumar P. Grading of Severity in Burn Patients. Annals of Plastic Surgery. 2010; 65: 74-79

Kumar P (2018) Burns Fluid Resuscitation with Considerations for Changing Target Goals. JSM Burns Trauma 3(1): 1038.

Received : 09 May 2018
Accepted : 09 May 2018
Published : 11 May 2018
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X